The Efficacy and Safety of Apixaban Versus Warfarin Are Preserved in Patients With Atrial Fibrillation and Extreme Body Weight: Insights From the Aristotle Study
Canadian Journal of Cardiology - Canada
doi 10.1016/j.cjca.2018.07.273
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV